After QRX yesterday I am wondering if any of small biotech funds will have to balance their books and if that will put even more pressure on ACL price if it wasn't already a factor in the last fortnight. Been a terrible month for biotech that thought they were close. Orbis took a large hit but I haven't followed their holding size over the years to know what they traded and were issued but 17mill hit has to hurt. Very sad but educational watching what has gone on over at QRX and the whole FDA approval process. Has got me reading back over ACL stuff from FDA and trial that's for sure.
After QRX yesterday I am wondering if any of small biotech funds...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable